AsianScientist (Dec. 4, 2019) – WuXi AppTec Research Service Division and BioSolveIT has launched a new virtual chemical space called GalaXi®.
Novel molecular entities are in high demand to combat diseases such as cancer, bacterial and viral infections, as well as illnesses of the central nervous system. Over decades, traditional compound libraries containing millions of compounds have been collected and curated.
However, many more compounds, though synthetically feasible, have traditionally been inaccessible due to physical and informatic limitations. The GalaXi® space is a combination of WuXi AppTec’s chemistry expertise and BioSolveIT’s software technologies, resulting in a chemical space housing billions of virtual molecules that can be mined within minutes and synthesized within a few weeks.
Dr. Christian Lemmen, CEO of BioSolveIT, noted that traditional virtual screening methods reach their limit at about hundreds of millions of molecules, whereas BioSolveIT’s search technology can work reliably with chemistry spaces of the size 1020..
“We used to be able to screen millions of compounds in seconds, but access to billions of compounds in minutes is just amazing,” said Dr. Steve Yang, executive vice president and chief business officer of WuXi AppTec. “This is exactly what our clients need. The pressure on research to come up with novel ideas is indeed enormous, both in terms of time and cost. With GalaXi® we take a large step forward in improving the productivity of new drug discovery and bring new medicines to patients faster.”
———
Source: WuXi AppTec; Photo: Shutterstock.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
